Fundraisers / Leerink Partners LLC
FundraiserRegistered broker-dealer
Leerink Partners LLC
FINRA 39011 · placing rounds since Jan 2016
60company rounds placed
15in the last two years, last Mar 2026
$5.4Bsold in the rounds they placed
5.0%typical commission; the median firm takes 4.9%
Named on 60 Form D filings as paid to sell the offering: 60 for operating companies. 1 registered agent named.
Quarter by quarter
Company rounds they placed in each quarter, from the filings.
323Q2223Q3524Q1224Q2224Q3424Q4225Q1325Q3225Q4426Q1
What they place
- Biotechnology62%
- Pharmaceuticals21%
- Other Health Care13%
- Other Technology4%
How big the rounds are
- Under $1M0
- $1M to $5M1
- $5M to $20M7
- $20M to $100M49
- $100M+18
Where the companies are
CA30MA15TN4NJ4NY4CO2PA2MD2
Rounds they placed
FiledIssuerIndustrySold
Mar 2026AN2 Therapeutics, Inc.Pharmaceuticals$40M
Mar 2026Immunic, Inc.Biotechnology$200M
Mar 2026Sensei Biotherapeutics, Inc.Biotechnology$349M
Jan 2026iBio, Inc.Biotechnology$26M
Nov 2025Galecto, Inc.Biotechnology$285M
Oct 2025Spruce Biosciences, Inc.Biotechnology$50M
Sept 2025OmniAb, Inc.Biotechnology$30M
Aug 2025SAB Biotherapeutics, Inc.Biotechnology$175M
Jul 2025Ikena Oncology, Inc.Biotechnology-
Feb 2025Tectonic Therapeutic, Inc.Biotechnology$185M
Jan 2025RAPT Therapeutics, Inc.Biotechnology$150M
Dec 2024Senti Biosciences, Inc.Biotechnology$38M
Dec 2024Aclaris Therapeutics, Inc.Pharmaceuticals$80M
Nov 2024Aviceda Therapeutics, Inc.Biotechnology-
Oct 2024OnKure Therapeutics, Inc.Pharmaceuticals$65M
Sept 2024Priority Private Care Management, Inc.Other Technology$28M
Aug 2024Tenax Therapeutics, Inc.Pharmaceuticals$100M
May 2024Eledon Pharmaceuticals, Inc.Biotechnology$50M
Apr 2024Benitec Biopharma Inc.Biotechnology$40M
Mar 2024Unicycive Therapeutics, Inc.Biotechnology$50M
Mar 2024Avidity Biosciences, Inc.Biotechnology$400M
Mar 2024Applied Therapeutics, Inc.Biotechnology$100M
Mar 2024Crinetics Pharmaceuticals, Inc.Biotechnology$350M
Feb 2024Kura Oncology, Inc.Biotechnology$150M
Aug 2023Gossamer Bio, Inc.Biotechnology$212M
Jul 2023Wellvana Health, LLCOther Health Care$16M
May 2023Eledon Pharmaceuticals, Inc.Biotechnology$35M
May 2023Upperline Health Holdings, Inc.Other Health Care$28M
May 2023Applied Therapeutics Inc.Biotechnology$30M
Mar 2023Wellvana Health, LLCOther Health Care$42M
Mar 2023Wellvana Health, LLCOther Health Care$65M
Feb 2023Spruce Biosciences, Inc.Biotechnology$54M
Jun 2022Abacus Insights, Inc.Other Technology$28M
Dec 2021Regulus Therapeutics Inc.Pharmaceuticals$35M
Nov 2021Cardurion Pharmaceuticals, Inc.Biotechnology$46M
Oct 2021ShouTi Inc.Biotechnology$100M
Aug 2021SPR Therapeutics, Inc.Other Health Care$20M
Aug 2021Rafael Holdings, Inc.Biotechnology$104M
Mar 2021Caribou Biosciences, Inc.Biotechnology$115M
Jan 2021DiCE MOLECULES HOLDINGS, LLCOther Technology$54M
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.
Often on the same rounds
Other fundraisers named on the same filings: the firms they syndicate with.
Founders who worked with them
No one has said so yet.
Worked with them? Say so
A badge for their site
It shows their latest standing in the quarterly rankings and links back here.
Is this Leerink Partners LLC?
Claim the page to describe your work in your own words. Free.